Otros idiomas Kissei Pharmaceutical Co., Ltd.

Acciones

4547

JP3240600001

Mercado cerrado - Japan Exchange Otros sitios de cotización 08:00:00 02/05/2024			Varia. Cinco días.	Varia. 1 de enero.
3.655 ^JPY	+1,67 %		+1,95 %	+18,28 %

04/01	Kissei Pharmaceutical recompra acciones por valor de 251 millones de yenes en diciembre de 2023	MT
2023	Kissei Pharmaceutical Co., Ltd. y Maruishi Pharmaceutical Co., Ltd. Anuncian el lanzamiento en Japón de KORSUVA®? Jeringa de inyección intravenosa para diálisis de 17,5ug y 25,0ug se lanzará en Japón para el tratamiento del prurito en pacientes sometidos a hemodiálisis	CI

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

Kissei Pharmaceutical Completes 6 Billion Yen Buyback Program	20/03
Kissei Pharmaceutical : Notice Concerning Status of Acquisition and Completion of the Company's Own Shares	19/03
Tranche Update on Kissei Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on May 8, 2023.	19/03
Kissei Pharmaceutical Co., Ltd.'s Equity Buyback announced on May 8, 2023, has closed with 1,909,900 shares, representing 4.18% for ¥5,999.99 million.	18/03
Kissei Pharmaceutical : Notice Concerning Status of Acquisition of the Company's Own Shares	01/03
Kissei Pharmaceutical Co., Ltd. Provides Dividend Guidance for the Year Ending March 2024	30/01
Kissei Pharmaceutical Repurchases 251 Million Yen Worth of Shares in December 2023	04/01
Tranche Update on Kissei Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on May 8, 2023.	04/01
Kissei and Maruishi Debut Injection for Dialysis-Related Itching	13/12
Kissei Pharmaceutical : KORSUVA® IV Injection Syringe for Dialysis 17.5μg, 25.0μg and 35.0μg to Launch in Japan for Treatment of Pruritus in Patients Undergoing Hemodialysis	12/12
Kissei Pharmaceutical Co., Ltd. and Maruishi Pharmaceutical Co., Ltd. Announces KORSUVA®? IV Injection Syringe for Dialysis 17.5ug, 25.0ug to Launch in Japan for Treatment of Pruritus in Patients Undergoing Hemodialysis	12/12
Kissei Pharmaceutical : Notice Concerning Status of Acquisition of the Company's Own Shares	01/12
Kissei Pharmaceutical : Introduces Natural Language Processing System	17/11
Japanese Shares Close Lower on Tuesday After Key Economic Data	07/11
Kissei Pharmaceutical's Fiscal H1 Attributable Profit Surges as Net Sales Gains	07/11
Kissei Pharmaceutical Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2024	06/11
Kissei Pharmaceutical Co., Ltd. Announces Second Quarter-End Dividend for the Year Ending March 31, 2024, Payable on December 4, 2023 and Provided Dividend Guidance for the Year Ending March 31, 2024	06/11
Kissei Pharmaceutical : Notice Concerning Status of Acquisition of the Company's Own Shares	01/11
Kissei Pharmaceutical Co., Ltd. Revises Consolidated Earnings Guidance for the First Half Ending September 30, 2023	27/10/23
Kissei Pharmaceutical : Notice Concerning Revisions to Financial Results Forecast	27/10/23

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Kissei Pharmaceutical Co., Ltd.

Acciones

4547

JP3240600001

Otros idiomas

Filtros